(Reuters) – Bristol-Myers Squibb Co said it would invest in Dutch biotech uniQure NV , joining other big drugmakers who have moved to gain a foothold in the promising gene therapy market.
UniQure’s shares jumped more than 55 percent on Monday after Bristol-Myers said it would pick up a 4.9 percent stake in the company.
19:39 $1M '100 percent Swiss Made' watch made of real Swiss cheese16
23:37 Here’s Why Netflix’s Share Price Just Hit a New All-Time High5
21:52 Netflix nears 94 million subscribers 10 years after streaming launch18
11:20 PE firm Warburg buys $121 million stake in Indian cinema operator PVR14